Euroapi S.A. (EPA:EAPI)

France flag France · Delayed Price · Currency is EUR
2.842
+0.036 (1.28%)
May 6, 2025, 3:42 PM CET
-1.66%
Market Cap 267.21M
Revenue (ttm) 919.20M
Net Income (ttm) -130.60M
Shares Out 95.23M
EPS (ttm) -1.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 27,151
Average Volume 104,860
Open 2.802
Previous Close 2.806
Day's Range 2.802 - 2.870
52-Week Range 2.260 - 4.540
Beta 0.65
RSI 62.07
Earnings Date Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. It offers their products to pharmaceutical, generic drug manufactu... [Read more]

Sector Healthcare
Founded 2020
Employees 3,187
Stock Exchange Euronext Paris
Ticker Symbol EAPI
Full Company Profile

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial Statements

News

There is no news available yet.